March 11. 2022
Lineage Cell Therapeutics Inc 10-K
Lineage Cell Therapeutics Inc, which is in the Biological Products (No Diagnostic Substances) [2836] industry, SEC 10-K filing on March 10, 2022 had 46760 (cleaned) words - 600 were utilized for the visualizations.
Top Words:
- may - 511 instances
- lineage - 471 instances
- 2021 - 327 instances
- clinical - 304 instances
- product - 295 instances
See the parsed data used in the visualization here.
View the actual filing on the SEC website here